Detail akcie Modular Medical Rg online

Business Summary: Modular Medical, Inc. is a development-stage medical device company. The Company is focused on the design, development, and commercialization of insulin pumps using technology to increase pump adoption in the diabetes marketplace. The Company's product seeks to serve both the type 1 and type 2 diabetes markets for those individuals requiring insulin. MODD1, its product, is a high-precision pump. MODD1's features include two parts - one reusable, one disposable - snap together to form the working system; one button interface; 90-day reusable, three-day disposable; disposable portion removable at any time from an adhesive-backed retainer, which remains in place, and no external controller required, no charging and no battery replacement. MODD1 comes with a variety of methods for the patient to wear the pump. Options include a baseplate with adhesive for attaching to the body that has features for holding the pump to the patient, and overwraps to hold the product to the patient.
Financial Summary: BRIEF: For the six months ended 30 September 2025, Modular Medical Inc revenues was not reported. Net loss increased 59% to $14.5M. Higher net loss reflects Innovative insulin pump segment loss increase of 59% to $14.6M. Basic Earnings per Share excluding Extraordinary Items increased from -$0.27 to -$0.26.